14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:SGYP
Delisted

Synergy Pharmaceuticals Stock Predictions

$0.0064
+0 (+0%)
At Close: Sep 17, 2019
Currently predicting for Wed, 8 May 2024

SGYP Predictions History

5 years ago
NameNotImportant predicted that SGYP for 2019-05-06 is going $0.0100 (56.25%)

5 years ago
Gp predicted that SGYP for 2019-03-11 is going $0.0400 (33.33%)

5 years ago
JS predicted that SGYP for 2019-03-11 is going $0.0300 (0.00%)

5 years ago
JS predicted that SGYP for 2019-03-05 is going $0.0650 (9.24%)

5 years ago
JS predicted that SGYP for 2019-03-01 is going $0.0920 (26.72%)

5 years ago
PumpTheseNumbers predicted that SGYP for 2019-03-01 is going $0.0910 (25.34%)

5 years ago
Gp predicted that SGYP for 2019-03-01 is going $0.130 (79.06%)

5 years ago
Steven.Byrd.102645 predicted that SGYP for 2019-03-01 is going $0.250 (211.72%)

Rank:

5 years ago
PumpTheseNumbers predicted that SGYP for 2019-02-25 is going $0.299 (24.53%)

5 years ago
JS predicted that SGYP for 2019-02-25 is going $0.288 (19.95%)

Click to get the best stock tips daily for free!

About Synergy Pharmaceuticals

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333,... SGYP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT